article thumbnail

Outcomes of a virtual CGM initiation service (virCIS) for primary care patients with diabetes [Diabetes and endocrine disease]

Annals of Family Medicine

Context: Continuous glucose monitoring (CGM) is now considered a standard treatment option in diabetes care. However, its adoption has been slower in primary care settings compared to endocrinology practices, resulting in unequal access for patients with diabetes. Setting: Primary care practices in Colorado. Two practices were FQHCs.

article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

In March 2024, FDA therefore approved semaglutide for secondary CVD prevention in overweight or obese adults. 4 Chronic Kidney Disease The FLOW trial randomized 3,534 patients with chronic kidney disease and type 2 diabetes and started treating them with s.c. over 40 months (ARR). semaglutide 2.4 mg or placebo for 52 weeks.

Diabetes 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Oregon-based medical group Northwest Permanente announces affiliation with The Permanente Medical Group of Northern California

Permanente Medicine

Consolidation of hospitals, medical groups, and health plans are occurring throughout the United States,” said Dr. Koh. Hospital Model of Care: NWP will work with TPMG on the Hospital Model of Care and Telecritical Care, a virtual care program for patients in the ICU. Kaiser Permanente in Northern California received 4.5

Medical 52
article thumbnail

The Physicians Foundation Announces New Recipient in Leadership Award Program, Recognized for Addressing Drivers of Health

The Physicians Foundation

is honored for his transformative work, connecting patients with primary care and critical health resources BOSTON, August 15, 2024 – The Physicians Foundation is proud to announce Jubril Oyeyemi, M.D., In July 2024, The Physicians Foundation also honored E. Jubril Oyeyemi, M.D., Mirna Mohanraj, M.D. ,

article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. Eric 20:51 And your deprescribing was on hospital discharge.

article thumbnail

How to manage GLP-1s in the hospital

Today's Hospitalist

Medical societies and hospitals are weighing in on periprocedural concerns in patients taking GLP-1s who need procedures or surgeries. That’s according to two internists who work closely with hospitalized patients who take GLP-1s. “I would not recommend starting a GLP-1 in the hospital.” Nor should they be.

article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025. The following is a summary of the spring meeting.